Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Aspects of care for the hepatitis C positive patient.

Wodak A.

Aust Fam Physician. 1998 Sep;27(9):787-90.

PMID:
9769525
3.

Advances in the treatment of hepatitis C.

Lawrence SP.

Adv Intern Med. 2000;45:65-105. Review.

PMID:
10635046
4.

Treatment of chronic hepatitis C virus infection - Dutch national guidelines.

de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):311-22. Review. Erratum in: Neth J Med. 2008 Dec;66(11):456. Dosage error in article text.

5.

New developments in the antiviral treatment of hepatitis C.

de Bruijne J, Weegink CJ, Jansen PL, Reesink HW.

Vox Sang. 2009 Jul;97(1):1-12. doi: 10.1111/j.1423-0410.2009.01187.x. Epub 2009 Apr 20. Review.

PMID:
19392783
6.
7.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

8.
9.

Therapy of chronic hepatitis C virus infection in HIV co-infected people.

Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

Curr Pharm Des. 2004;10(17):2111-22. Review.

PMID:
15279550
10.

Projecting future complications of chronic hepatitis C in the United States.

Davis GL, Albright JE, Cook SF, Rosenberg DM.

Liver Transpl. 2003 Apr;9(4):331-8.

11.

Management issues in chronic viral hepatitis: hepatitis C.

Sievert W.

J Gastroenterol Hepatol. 2002 Apr;17(4):415-22. Review.

PMID:
11982722
12.

The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.

Almasio PL, Venezia G, Craxì A.

Panminerva Med. 2003 Sep;45(3):175-82. Review.

PMID:
14618115
13.

Management of chronic hepatitis C.

Asselah T, Boyer N, Ripault MP, Martinot M, Marcellin P.

Minerva Gastroenterol Dietol. 2007 Mar;53(1):9-23. Review.

PMID:
17415342
14.

Novel approaches for therapy of chronic hepatitis C.

Stauber RE, Stadlbauer V.

J Clin Virol. 2006 Jun;36(2):87-94. Epub 2006 Mar 20. Review.

PMID:
16546442
15.

Prevention of hepatocellular carcinoma complicating chronic hepatitis C.

Ueno Y, Sollano JD, Farrell GC.

J Gastroenterol Hepatol. 2009 Apr;24(4):531-6. doi: 10.1111/j.1440-1746.2009.05814.x. Review.

PMID:
19368633
16.

Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.

17.

The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.

Gidding HF, Topp L, Middleton M, Robinson K, Hellard M, McCaughan G, Maher L, Kaldor JM, Dore GJ, Law MG.

J Gastroenterol Hepatol. 2009 Oct;24(10):1648-54.

PMID:
19798783
18.
19.

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.

Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, Puoti M, Soriano V, Tural C; EACS Executive Committee.

HIV Med. 2008 Feb;9(2):82-8. doi: 10.1111/j.1468-1293.2007.00535.x.

20.

Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.

Mulhall BP, Younossi Z.

J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S23-7.

PMID:
15597024

Supplemental Content

Support Center